与代谢功能障碍相关的脂肪性肝病和心血管系统
Antonis A Manolis1, Theodora A Manolis2, Apostolos Vouliotis3
1Department of Medicine, Elpis General Hospital, Athens, Greece.
与代谢功能障碍相关的脂肪性肝病 (MASLD) 是与心血管疾病相关的日益严重的健康问题. 早期诊断和管理MASLD,包括改变生活方式和向治疗,对于改善患者的治疗结果至关重要.
科学领域:
- 肝病学和代谢疾病
- 心血管医学 心血管医学
- 临床药理学 临床药理学
背景情况:
- 代谢功能障碍相关的脂肪性肝病 (MASLD),以前是非酒精性脂肪性肝病,影响25-30%的成年人,高达70%的糖尿病患者.
- MASLD是一种多系统性疾病,增加了2型糖尿病,心血管疾病,慢性病和肝细胞癌的风险.
- 心血管事件是MASLD患者的主要死亡原因,这强调了肝脏和代谢健康之间的联系.
研究的目的:
- 审查MASLD的流行病学,诊断,并发病症和管理策略.
- 要突出MASLD与动脉样硬化心血管疾病之间的显著联系.
- 讨论MASLD当前和新兴的治疗方案,包括生活方式修改和药物治疗.
主要方法:
- 对有关MASLD患病率,风险因素和临床结果的文献进行系统审查.
- 对诊断标准的分析,包括肝肥胖症和心脏代谢风险因素.
- 评估管理策略,包括生活方式的改变,并发症控制和药物干预措施.
主要成果:
- MASLD非常普遍,特别是在糖尿病人群中,并且与诸如肥胖,高脂血症和高血压等众多代谢并发症有关.
- 心血管疾病是导致死亡的首要原因,强调了综合管理的关键需要.
- 生活方式的修改,他类药物和像resmetirom这样的特定药物在管理MASLD及其并发症方面显示出希望.
结论:
- MASLD是一个重要的公共卫生问题,具有深刻的心血管影响.
- 包括生活方式变化,并发病率优化和向治疗在内的综合管理对于改善预后至关重要.
- 对MASLD向药物治疗的进一步研究是有必要的,特别是在非脊髓炎的疾病阶段.
更多相关视频
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
07:12Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
相关概念视频
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
